{"name":"DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company","slug":"dice-therapeutics-inc-a-wholly-owned-subsidiary-of-eli-lilly-and-company","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Dermatology","slug":"dermatology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"DC-806","genericName":"DC-806","slug":"dc-806","indication":"Moderate to severe atopic dermatitis","status":"phase_2"}]}],"pipeline":[{"name":"DC-806","genericName":"DC-806","slug":"dc-806","phase":"phase_2","mechanism":"DC-806 is an anti-inflammatory monoclonal antibody targeting the IL-17 receptor.","indications":["Moderate to severe atopic dermatitis"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTFBBeWgyR1RtQnUzT3FsbEFCSlA5U1ZuMFNNSzdmSlRZXzlIaUptWkZXNy1XSmh4a1F6WkdWM2dxS2I0bER5YjZLcU44dDNoeTd5Vm14ZF80V1RUdTJJLUZwTlc5NngxSFE4UUVsV01Lb1JrWUFz?oc=5","date":"2025-01-13","type":"deal","source":"Fierce Pharma","summary":"The top 10 biopharma M&A deals of 2024 - Fierce Pharma","headline":"The top 10 biopharma M&A deals of 2024","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxORVFEdVh2b3ZPNnhVVlU0Z0xzdlpnOTZCbi1ZSUFhM2lWMnoya1IySEtiRVB0Tl9UV3ozQ3M5T0pRZ0xjRnpCR1RjYUt4ekd0YW5OT29YcjAxM3FObF9fRmZfMWstc2lLdkNsNi1ZVkQ1aHlMWFZnTThNQmpYcmVQQzhscTZXcFBLRnZuQWxjR0M2WDVfMlBjWnRXcG1zSGlyREZzYzV4VWFOS1NGSEpaOWQ1ck9vRUVQaWhSRFZGQ0YyS1BfMkVPTlhpX3NtS0Frd0tOdEhxTWNOSHlpNUVJVWd2SWNJQzZiTU9VQg?oc=5","date":"2024-10-16","type":"pipeline","source":"GlobeNewswire","summary":"80+ Pharma Companies Unite to Shape the Future of RNA-Based Therapeutics | DelveInsight - GlobeNewswire","headline":"80+ Pharma Companies Unite to Shape the Future of RNA-Based Therapeutics | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxQa1E0OVNWX0dWQ0RXbnVTQy1vRnVxQ1pHcFZnVzVTOFpsOEplN2kxa014SFQ3YzNWalFpS0MyT1VkN2VxWnh1a2NRbkhnQi1lMHI4MjZFYjNwNFgycHZaYy1xcnJhSjRwREJkTnJzb3NuM29SRGc5VE1wbmxpal9PdEVuTFNXMVljT295MldtVkctUVNtMjVZNUN4S1ZJMlByZVQwUVlDNGpub29WcWJJMXdkUQ?oc=5","date":"2024-03-02","type":"pipeline","source":"Genetic Engineering and Biotechnology News","summary":"Novo Nordisk Expands Boston Area Research and Early Development - Genetic Engineering and Biotechnology News","headline":"Novo Nordisk Expands Boston Area Research and Early Development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTFBYSmY3ZWJDOFduUkJqcmNYV2R6Rzc1YU9VVi1QcHZ2NW5mVXlWRVRocGYydmw1ZDNiSmpFSk9KcGVPQm8tTXRmRzF4YnAzRTFVcF9vYmZ6dkJmLXMwNmszMW96RTdtMFlacFloODUwSFpyV2VhbWd3?oc=5","date":"2023-12-22","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech M&A Tracker 2023: BMS, AbbVie drop billions for neuropsychiatry biotechs - Fierce Biotech","headline":"Fierce Biotech M&A Tracker 2023: BMS, AbbVie drop billions for neuropsychiatry biotechs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxOM21fRGpRejlrSWVkVXotS0NOdW5Za3Jva1l1V0Jjd195TVBPNkJ4aDlndFB4aEJleFlFbDh5dFRlbHhMR3U3eG1IOWJfYXNXaG5CTjlPSmM3eXRtYlNnZmZxeHBJbTNXUXJzNmwxTnA0dHNaRHE0NS1VeU1paFZEc2ZFcjVUTGNTeXVjMDl2TmhwYkF6MnNvXy1wNjhNZ0g1YzAwd0k2WQ?oc=5","date":"2023-07-14","type":"deal","source":"Fierce Biotech","summary":"Hungry for more, Lilly tops off weight loss pipeline with $1.9B deal to acquire Versanis - Fierce Biotech","headline":"Hungry for more, Lilly tops off weight loss pipeline with $1.9B deal to acquire Versanis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxONkpyTk54N2NlRHFRaGREQ0Y5TVlXM0U2MFZGdG1SemlqSWxqeVpUSXNzdEJTTmdQSzNhOEZtendNQ2FlSEVVSlp3U19Gb3FjS3h3dDByTHRKTlFQVk5yTE9xeUN0Mm03VU5jdVlXX0U5VGNINEVLWXk4QkxTejlqamtqc2x5b2RENXZyRGxCMGI1SFhaUzNfOHhyajZXanRtMWR0d25naXpuN0hVbGo1U2pZdnZCMkRNYUwyZ19HaDZTUzhiTUVfSHhqOTJBUnZ0WVktVGNKUEttWjNpeno1SG9IYmd1QlpQLWZrWGtYQ2pOVlRSUTlTRFBzcmJpbE0?oc=5","date":"2023-06-23","type":"pipeline","source":"proactiveinvestors.com","summary":"Why are healthcare stocks a safe haven during recessions? A look at companies making moves this week - proactiveinvestors.com","headline":"Why are healthcare stocks a safe haven during recessions? A look at companies making moves this week","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxOXzkxUXItSHZLS3o2V3p6aXVJNjlDUUhqdGRtVVpxLXpCTUFoT0hNa0lQb3ZKVXdDMVdXbERzeUFSYlFvNFgwZXBxU1QzVU53eGJBR1lRSE1kdVk4T05wSTB3cDJyU0pkWmxPdE9sTlVKWVNKQTM4ejBCTHlENW1BQklLNDJVLVZqUnRqc0NpckstVHlPeURfOFdMeGhPRF85eXJBQXduaXFwenJDSUtfeFVGN1R2eTFrWTBFSzlZMVg?oc=5","date":"2023-06-20","type":"deal","source":"Eli Lilly","summary":"Lilly to Acquire DICE Therapeutics to Advance Innovation in Immunology | Eli Lilly and Company - Eli Lilly","headline":"Lilly to Acquire DICE Therapeutics to Advance Innovation in Immunology | Eli Lilly and Company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxNelBuQ1dNaGIxSWZJdU5tTThBRzRJem5ERi1oNG1fb3lyQlBJeVE1TkRfYXJrbjR1Um02c0E0YnlBT0I3SVdLY29EYkMtTklIV0ZsUVg2Tmctdm9Ba0ZRT21kUHRrckpoU3JDUGwtNFlWeHREeE5MOEptbWUxOTNPQWJOOENJRjQxSkRvTTVQTzhzNV9CSzh3dzN5bnFKLWlELVd3ellrYUZaOFRFR25UbENyaXliczZwTm5Hd1hGNlFOSnlo?oc=5","date":"2023-06-20","type":"deal","source":"PR Newswire","summary":"Lilly to Acquire DICE Therapeutics to Advance Innovation in Immunology - PR Newswire","headline":"Lilly to Acquire DICE Therapeutics to Advance Innovation in Immunology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxOZnFvSjFFMDhWWkpCYjNhUG44UTlRWGR5eXhSdnNTNEIxem1jSkV3WldMd1d0U3d4c1hYYm5kS29aQjY0R0h0enYzOHhFeW0wc3dQdUFScGo1U09hbUtYWnRBTE9DbHNBbUdzU2FXQXY0OE1sb0pCZldrb0tXamxGU2tmSjQ2OXIwNGY2TEtWQUExYW5UM0dxaTZjVERrME1wcmxPSTRCVkY5Zm0zWk5DeTNhY1hfaHU0Zy1J?oc=5","date":"2023-03-24","type":"trial","source":"Healio","summary":"Izokibep shows promise in early phase 2 hidradenitis suppurativa trial - Healio","headline":"Izokibep shows promise in early phase 2 hidradenitis suppurativa trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPUWxYeDhqQmhLdjdpUTJsMUlnMnpKSHF4QXM2dVRrU0NxM3lCblZJbmxVQkwyaTFZNWh1ME1YVkR1UERZVURyczhXeEc1ek10bkxtTThrU28wbDBWSmpCdlIxUmQ0bTRlTHZfcVg2RkFRZU9XSFI5dk14bEdwNW5DSVJ1X1B6amZRUENxTzBjY0VKZHJaUENWOXZwdGIwTHlkd3h6emU2MHJIUQ?oc=5","date":"2019-11-25","type":"deal","source":"The Business Journals","summary":"Dicerna CEO talks market rivals after signing last partnership deal - The Business Journals","headline":"Dicerna CEO talks market rivals after signing last partnership deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQNG5lNXRxamdaQmhRVUtDNjFqWXRibVRhZlFvOGg5RjM1VV9ldEIxN0dZbF9rN0l5U3Flcmw4T01ZcmRvc01RS25DVENPd19TZ3NGLWx1VGR3X012dWlhZkJNMnRyTll3NEQtTC1uUTQ0V00tV0hIZzN4R2dJWFR4Ymx2R1JyLWtzMVo4T01yRklGaUVhM1U1STF4NlZGUS1OempIbnpVMWllb0FiMlE?oc=5","date":"2019-01-07","type":"deal","source":"Eli Lilly","summary":"Lilly Announces Agreement To Acquire Loxo Oncology - Eli Lilly","headline":"Lilly Announces Agreement To Acquire Loxo Oncology","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}